Objective: to develop and verify a high fat diet-induced type II diabetes mellitus model. Materials and methods: C57BL/6 male mice were used as the object of study. We developed an experimental diet in which 59% of the total caloric content was from fat. The concentration of glucose in the blood was measured using a portable glucometer PKG-02.4 Satellite Plus (ELTA Company, Russia). Blood samples were obtained by puncture of the caudal vein. Insulin concentrations in the blood plasma of mice were determined by ELISA using the Ultra-sensitive mouse insulin ELISA kit (CrystalChem, USA). Statistical data processing was carried out using the statistical analysis package Statistica 8.0.
INTRODUCTION
Type II diabetes mellitus, which accounts for at least 90% of diabetes cases, is associated with insulin resistance in tissues and elevated blood glucose levels [1, 2] . Most patients with this form of diabetes are obese, and obesity itself causes some degree of insulin resistance [3] [4] [5] .
Insulin sensitivity in tissues at the post-receptor level is reduced in type II diabetes mellitus. The defect in the signal transduction from β subunit of insulin receptor tyrosine kinase leads to a decrease in cell membrane permeability to glucose, due to reduced translocation to the plasma membrane of the glucose transporter protein GLUT 4. As a result, insulin resistance develops and in response to it, hyperinsulinemia occurs, which can compensate for insulin resistance and support normoglycemia for a certain time. Excess insulin by the feedback mechanism further reduces the sensitivity of the receptors to insulin. Glucose utilization by tissues decreases, gluconeogenesis increases in the liver, which leads to hyperglycemia. Also, in type II diabetes, the sensitivity of pancreatic β-cells to glucose stimulation is reduced, which leads to a decrease in insulin secretion. As a result, the first phase, the early phase of insulin secretion, is delayed or absent; gluconeogenesis increases in the liver and hyperglycemia develops. Type II diabetes may be associated with abdominal obesity, which results in insulin resistance [6] .
Despite significant achievements, a number of molecular mechanisms of energy metabolism regulation in normal conditions and in pathology remain poorly understood, while new approaches to prevention and treatment of diabetes are needed [7] .
An important and promising direction in thesearch fornew approaches to the treatment of this disease is the utilization of experimental models. To model obesity and diabetes in laboratory animals, several types of models are used, which can be divided into two groups: genetic and nongenetic.
To reproduce type II diabetes mellitus type 2 in rodents, chemical cytotoxic diabetogenic substances, streptozotocin, dexamethasone, etc., are most often used, or the combined effect of chemical and dietary factors [8] . Cytotoxic agents have different mechanisms of damaging effects on the beta cells in the pancreas, so their use can be very limited [9] . In addition, most well-known streptozotocin models develop diabetes with severe insulinopenia without obesity, dyslipidemia, and insulin resistance, which, as a rule, is not characteristic of type II diabetes [10] .
One of the models for the development of diabetes is keeping animals on a high-fat diet. A high-fat diet can lead to obesity, hyperinsulinemia and altered glucose homeostasis due to inadequate compensation from the islets [11] . Since obesity in this case is caused by manipulations of nutrition, and not with cytotoxic substances, it is believed that such models are more similar to the disease in humans.
Objective: to develop and verify a high fat dietinduced type II diabetes mellitus model.
MATERIALS AND METHODS
C57BL/6 male mice were used in the study. The mice were obtained from the animal facilities of theTomsk National Research Medical Center of the Russian Academy of Sciences at the Research Institute of Pharmacology and Regenerative Medicine named after E.D. Goldberg. The age of the mice at the start of the experiment was 2 weeks. The regime of keeping animals was the following: day/night: 12/12, the sunrise is at 6:00, free access to food and water, the temperature in the room is 24 °C.
Two groups were formed: 1) mice on a standard chow diet (n = 12) -control group; 2) mice on a high fat diet (n = 12) -experimental group.
The control group was fed with food for laboratory animals Prokorm (Biopro, privately-held company, Novosibirsk), in which fats accounted for 18% from the total calories intake. The composition of the feed was wheat, barley, bran, corn gluten, fish meat, protein feed, sunflower oil and soybean meal.
For the experimental group, we developed a diet that included the Prokorm feed described above (50%), animal (lard) (20%) and vegetable (sunflower oil) (10%) fat, sugar (15%) and dry milk (5%). Products were ground in a blender to a homogeneous mixture, after which the mass was formed into granules with a diameter of up to 10 mm and dried in an oven at 30 °C. The feed was prepared for 5 days and stored at +4 0 C. The diet complied with the following criteria: 59% of the calories accounted for fats, including animal fats (2/3 of the specified amount) and vegetable fats (1/3 of the specified amount); the fatty acid composition is presented in table 1.
The experiment continued within 16 weeks. The body weight test was carried out every two weeks. The glucose tolerance test was conducted on the 1st and 16th week. Insulin concentration was measured at week 1 and 16 immediately after and 15 minutes after intraperitoneal glucose administration.
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INTRAPERITONEAL GLUCOSE TOLERANCE TEST
The concentration of glucose in the blood was measured using a portable glucometer PKG-02.4 Satellite Plus (ELTA Company, Russia). Blood samples were obtained by puncture of the caudal vein.
For the glucose tolerance test, the mice were fasted for 4 hours, maintaining free access to water, the animals were weighed in the morning and the glucose concentration in the blood was determined (0 min). Then, a solution of 40% glucose (2 g/kg body weight) (carbohydrate load) was injected intraperitoneally to the animals [12] . The concentration of glucose in the blood was determined at 15, 30, 60 and 120 minutes after carbohydrate loading [13] . The maximum achievable concentration, time to reach the maximum and time to return to the initial level were estimated, and the area under curve (AUC) was also calculated ( Figure 2B ).
MEASUREMENT OF INSULIN CONCENTRATION IN BLOOD PLASMA
Blood samples were obtained by puncture of the caudal vein. Blood was collected in Microvette Sarstedt capillary tubes (Germany) 200 μl with K3EDTA.
The samples were centrifuged immediately after blood collection for 6 minutes at 10,000 rpm at 4 °C. Plasma was stored frozen at a temperature of -80 °C. Insulin concentration in the blood plasma of mice was determined by ELISA using the Ultra-sensitive mouse insulin ELISA kit (Crystal-Chem, USA). Measurement of the optical density of the samples was carried out using a microplate spectrophotometer Anthos. The calculation of the optical density of the samples was carried out at a wavelength of 450 nm and the reference wavelength was 620 nm.
To assess insulin resistance, we calculated the HOMA-IR Insulin Resistance Index (Homeostasis Model Assessment of Insulin Resistance), an indicator derived from Matthews D.R. et al., 1985, associated with the development of a mathematical homeostatic model for evaluating insulin resistance [14] . The calculation was performed according to the formula HOMA-IR = (fasting glucose (mmol / l) x fasting insulin (μED / l)) / 22.5.
Statistical data processing was carried out using the statistical analysis package STATISTICA 8.0. The level of significance when testing the hypothesis that two samples belong to the same general population was estimated by the Kruskal-Wallis ANOVA test. The data were presented as Xср ± SE.
The study was approved by the local ethical committee of the Biological Institute of the TSU (protocol Nо. 11 of September 24, 2015).
RESULTS
As a result of feeding mice with high fat diet, obesity developed in the animals. The dynamics of body mass change over 16 weeks in animals of the control and experimental groups is presented in Figure 1 . The identified excess of body weight as opposed to the control can be interpreted as obesity. Many authors define obesity as an increase in body weight by more than 25% [8, 9, 10] . At week 7, there is a significant increase in body weight in the mice from the experimental group. The body weight of the experimental animals exceeded the weight of animals in the control group by 18%. At week 8, the differences in weight rose to 32%. By the end of the experiment, the weight of mice on a high fat diet had been 50% higher than the weight of the animals in the control group (Figure 1) . Hyperglycemia in mice of the experimental group was observed from the 8th week of the study (6.63 ± 0.91 mmol/l versus 4.4 ± 1.3 mmol/l in the control). By the end of the experiment in mice of the experimental group, the degree of glucose absorption decreased. After 15 and 30 minutes after the carbohydrate load in the mice of the experimental group, the level of glucose in the blood exceeded that of the control group by 13%. The same ratio persisted after 30 minutes. Within 60 minutes, the blood glucose level in the control group began to gradually decrease, whereas in the experimental group the index increased and the differences with the control were 41%. After 2 hours, the glucose level in the control group almost returned to the initial level, while in the experimental group it remained elevated by 57% (Figure 2A ). In the control group, the maximum rise in the glucose concentration was observed at the 30th minute and was 15.46 ± 1.2 mmol/l. In mice of the experimental group, the maximum concentration was reached at the 60th minute and amounted to 17.7 ± 2.3 mmol/l. The area under the curve (AUC) in the control group was 1424.6 ± 218.7 min * mmol/l; in the experimental one it was1851.7 ± 254.5 min * mmol/l (p <0.05) ( Figure 2B ). The decrease in glucose is called the hypoglycemic phase and indirectly reflects the rate of insulin production and the sensitivity of tissues to this hormone. Prolongation of this phase is characteristic of type II diabetes mellitus, which was observed in the experimental group of mice in this study. Figure 3 shows the insulin concentration in the blood plasma of mice before and after the glucose administration. In mice of the experimental group, the insulin level exceeded 3 times the value in the control group both before and 15 minutes after the administration of glucose.
Оригинальные статьи
higher than in the control group [8, 9, 10] ), hyperglycemia, reduced glucose tolerance and hyperinsulinemia. All these facts confirm the adequacy of the developed experimental model of type II diabetes mellitus. The criteria for the adequacy of the model, therefore, are the following: the dynamics of body mass; hyperglycemia and glucose tolerance test results, including the area under the glucose concentration curve for the glucose tolerance test (AUC).
At the same time, a high concentration of insulin in the blood of animals of the experimental group indicates that the disorders were formed only in muscle tissue, while the sensitivity to glucose of pancreatic β-cells remains. This allows us to make a conclusion about the relative adequacy of the developed model: alterations in the muscular tissue, but not in the pancreas, are modeled. Perhaps, the formation of glucose resistance on the part of β -cells in the pancreas requires a longer period.
The created model can be especially useful in a wide range of studies on insulin resistance, diabetes and obesity. It will provide a better understanding of the pathogenesis of the diseases, and can also be used for experimental verification of the effects of therapeutic interventions.
The calculation of HOMA-IR gave the following results: in the control group at the 16th week of the experiment it was 3.62 ± 0.48; and in the experimental one -19.85 ± 3.07 (p <0.001).
Typically, type II diabetes is characterized by insulin resistance. As the blood glucose concentration continues to rise, it promotes the release of more insulin.
CONCLUSION
The results show that a high-fat diet in mice leads to an increase in body weight and development of obesity (body weight is more than 25%
